Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis.

Miguel BurgosIván Cavero-RedondoCelia Álvarez-BuenoEva Maria Galan-MoyaAtanasio PandiellaEitan AmirAlberto Ocaña

Published in: Therapeutic advances in medical oncology (2022)

High expression of CEACAM6 is associated with worse OS and DFS in different malignancies. CEACAM6 is a target for the future development of novel therapeutics.

Keyphrases

papillary thyroid
poor prognosis
small molecule
squamous cell
current status
squamous cell carcinoma
binding protein
long non coding rna